Skip to main content
Caplight Logo









Liberate Medical

Liberate Medical

Private
Crestwood, KentuckyHealthcare & Life Scienceshttps://liberatemedical.com/

Last Round

Grant

Apr 9, 2024

Total Funding Raised

$14.36M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Liberate Medical is a medical device company that develops non-invasive neuromuscular electrical stimulation technology designed to reduce the duration of mechanical ventilation for patients with pulmonary disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

respiratory muscle stimulationneuromuscular electrical stimulationNMESmechanical ventilationventilator weaningrespiratory muscle atrophymedical deviceICU technologyclinical trialsventilator weaning protocolnon-invasive ventilationrespiratory therapycritical care equipmentmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Liberate Medical Comparables

Compare Liberate Medical with similar companies based on industry and business-model similarity.

Liberate Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stimdia Medical
92%
Lungpacer Medical
89%
Tesai Care
88%

Liberate Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 9, 2024
Series BJul 5, 2023
GrantFeb 20, 2019
GrantSep 15, 2016
GrantJul 1, 2014

Liberate Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    Job posting indicates the company is pre-revenue.

  • Mar 10, 2026

    Product received FDA Breakthrough Device Designation, EUA, and CE marking.

Liberate Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Liberate Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Liberate Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersCrestwood, Kentucky
Employee Range15
Year Founded2013
Last FundingApr 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?